https://www.newswise.com/articles/tofacitinib-shows-promise-in-scleroderma-patients-researchers-optimistic-for-next-phase-of-study
0
0
10/6/22 at 7:05pm
Organization
Newswise
The drug tofacitinib was well tolerated among patients with early scleroderma, primarily affecting the protein interferon both in fibroblasts and keratinocytes.
Create an account
or login to join the discussion